Appendix B: Panel Roster and Financial Disclosures
Pharmacology
| Member | Institution | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Jomy George | National Institutes of Health | None | N/A |
| Emily Heil | University of Maryland, School of Pharmacy | Lexi-Comp | Consultant |
| Safia Kuriakose* | National Institutes of Health | None | N/A |
| Alice Pau | National Institutes of Health | None | N/A |
| Charles Peloquin | University of Florida, College of Pharmacy | None | N/A |
| Key: * = Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. |
|||
Download Guidelines
- Section OnlyPDF (276.93 KB)
- Full GuidelinePDF (5.23 MB)
- Tables OnlyPDF (1.27 MB)